Skip to content
ClearSphere Market

TikTok Content Creators Driving Parallel Market for Unapproved Weight-Loss Drug

A shadow market for unapproved slimming drugs is propelled by social media fitness personalities and sellers on messaging platforms, according to new investigations.

Investigational Drug Acquiring Popularity Online

Retatrutide, which is still in clinical trials, is being advertised by social media influencers for its alleged fat-burning properties. Followers are encouraged to message these accounts directly for source information, while also obtaining discount codes.

Active Commerce on Messaging Platforms

Additionally, a robust market exists on Telegram, where communities with thousands of members share comparison photos, administration instructions and claims of rapid British shipping. Vendors market the substance there before redirecting buyers to other platforms for purchases.

Understanding Retatrutide

This medication is an investigational injection created by US drugmaker Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Early trials suggest it could help individuals lose up to 25% of their body weight. Referred to as the “triple G”, the drug is being hailed online as the next Ozempic.

Medical Professionals Express Worries

Nevertheless, doctors and pharmacists have cautions that the sale of what remains an unlicensed drug in the United Kingdom is worrisome and could lead to users injecting products of uncertain source.

Several professionals stated the popularity for retatrutide could be connected to the rising price of approved slimming products such as Mounjaro.

Regulatory Position and Enforcement

Selling retatrutide on TikTok or messaging apps is illegal in the United Kingdom, as it is an unlicensed drug that must not be marketed or supplied for human use under the Human Medicines Regulations 2012.

Several influencers try to sidestep the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted substance, but promotion and supply can still violate pharmaceutical, marketing, and consumer laws, potentially leading to fines, prosecution or prison.

Platform Reaction and Material Elimination

Based on TikTok, the service has removed problematic material and prohibited related hashtags and search suggestions. The company stated it was committed to keeping the service safe and investing in strengthening enforcement strategies.

Digital Marketplace Activities

Investigations also discovered communities with up to 9,000 members selling retatrutide using Telegram's built-in search feature, which functions like a online catalog. Entering “retatrutide” immediately brings up channels with numerous of users, populated with images of slimming results, positive reviews and detailed instructions for preparing or injecting at residence.

After minutes of joining one group, a vendor posted WhatsApp details, where the majority of transactions occur. The vendor sent an guidebook and promised delivery within two days. When asked whether the substance was genuine, one vendor said: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one asked about weight, health issues or past usage.

Product Information and Pricing

Inside these groups, messages display dark colored packages with Royal Mail labels, stating to include new batches. One message read: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, mixed at residence with sterile water, or ready-to-use pens usually priced at £160 for 20mg. When asked how much time a pen should be used, vendors give contradictory responses ranging from a few weeks to “depends on your body”.

Service Moderation and Safety Actions

A spokesperson for Telegram said it actively moderated dangerous material on its platform including content that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“Individuals are administering materials they cannot confirm. Even if the science behind retatrutide is valid, these digital versions may not contain what they claim,” said a pharmacy expert, the head of pharmacy at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor connected the increase in interest to current price rises for approved slimming drugs such as Mounjaro. “With costs increasing, individuals are turning to online platforms. But fake treatments are extremely dangerous. You can’t be certain what’s contained or whether the environment they were made in was clean,” she said.

Her staff has previously seen individuals injured by personal administration from unverified sources. “We recognize the disappointment, but buying from Telegram or WhatsApp is taking chances with your well-being,” stated the doctor. “These materials could be contaminated or improperly measured.”

Producer Statement

A representative from the pharmaceutical company said the substance was in third stage research studies and had not been evaluated or approved by any government authority globally. “Consequently at this point no one can market [it] for human use,” they explained, noting that any product “falsely representing itself as a company experimental product not yet approved … may expose users to possibly serious health risks”.

By

Kim Hernandez

Elena Voss is a market analyst and e-commerce enthusiast with over a decade of experience in product sourcing and consumer trends.

ClearSphere Market

Type to search articles.